EWTX261120C00034000
EWTX Nov 20 2026 34.00 Call
optionOPRA
InactiveAug 28, 2026
11.20USD+7.692%(+0.80)1Vol10OI
Loading…
Underlying
Underlying Price
$39.57
Type
Call
Strike
34
Expiration
Nov 20, 2026
DTE
44d
Moneyness
ITM
Intrinsic
$5.57
EWTX 34 Call Across Expirations
| Expiration | DTE | Last | Change | Vol | Open Int |
|---|---|---|---|---|---|
| Oct 16, 2026 | 9d | — | — | 0 | 0 |
| Nov 20, 2026 | 44d | $11.20 | +7.69% | 1 | 10 |
| Dec 18, 2026 | 72d | — | — | 0 | 0 |
| Jan 15, 2027 | 100d | — | — | 0 | 0 |
| Feb 19, 2027 | 135d | — | — | 0 | 0 |
EWTX Nearby Strikes · Nov 20, 2026
| Strike | Last | Change | Vol | Open Int | Moneyness |
|---|---|---|---|---|---|
| 28 C | $14.69 | +33.55% | 5 | 5 | ITM |
| 29 C | — | — | 0 | 0 | ITM |
| 30 C | $11.70 | +14.26% | 3 | 3 | ITM |
| 31 C | — | — | 0 | 0 | ITM |
| 32 C | $13.50 | +43.62% | 3 | 1 | ITM |
| 33 C | $12.50 | +13.64% | 10 | 2 | ITM |
| 34 C | $11.20 | +7.69% | 1 | 10 | ITM |
| 35 C | $8.30 | -25.23% | 1 | 2 | ITM |
| 36 C | $13.80 | +90.61% | 3 | 7 | ITM |
| 37 C | $6.68 | -36.20% | 1 | 113 | ITM |
| 38 C | $10.10 | +42.25% | 1 | 2 | ITM |
| 39 C | $9.39 | +55.21% | 1 | 1 | ITM |
| 40 C | $3.50 | -18.79% | 8 | 27 | OTM |
EWTX Profile
edgewise therapeutics is a biotechnology company focused on developing novel therapies for diseases involving skeletal muscle. the company is headquartered in boulder, co and received its series a financing from orbimed.